Cargando…

Assessment of disease control in allergic rhinitis

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative has had a significant impact, by raising awareness of allergic rhinitis (AR) and improving the diagnosis and treatment of AR sufferers. ARIA classifies the severity of AR as "mild" or "moderate/severe" on the basis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demoly, Pascal, Calderon, Moises A, Casale, Thomas, Scadding, Glenis, Annesi-Maesano, Isabella, Braun, Jean-Jacques, Delaisi, Bertrand, Haddad, Thierry, Malard, Olivier, Trébuchon, Florence, Serrano, Elie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615946/ https://www.ncbi.nlm.nih.gov/pubmed/23419058 http://dx.doi.org/10.1186/2045-7022-3-7

Ejemplares similares

Discriminating severe seasonal allergic rhinitis. Results from a large nation-wide database
por: Caimmi, Davide, et al.
Publicado: (2018)

Optimal management of allergic rhinitis
por: Scadding, Glenis K
Publicado: (2015)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

Rhinitis and Sinusitis
por: Scadding, Glenis K.
Publicado: (2008)

Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules
por: Tanno, Luciana Kase, et al.
Publicado: (2017)

Perception and control of allergic rhinitis in primary care
por: Demoly, Pascal, et al.
Publicado: (2020)

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis
por: Leaker, Brian R., et al.
Publicado: (2015)

Maternal diet before and during pregnancy and risk of asthma and allergic rhinitis in children
por: Baïz, Nour, et al.
Publicado: (2019)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Upper Airway Disease: Rhinitis and Rhinosinusitis
por: Scadding, Glenis K., et al.
Publicado: (2012)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Rhinitis, sinusitis and ocular disease – 2091. The MSYPQ: repeatability and applicability to rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice
por: Santos, Alexandra F, et al.
Publicado: (2015)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

The clinical burden of allergic rhinitis in five Middle Eastern countries: results of the SNAPSHOT program
por: Al-Digheari, Ahmed, et al.
Publicado: (2018)

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm
por: Scadding, Glenis Kathleen, et al.
Publicado: (2021)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study
por: Demoly, Pascal, et al.
Publicado: (2022)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

P07 - Treatment load in the therapy management of allergic rhinitis: a UK retrospective database study
por: Carter, Victoria, et al.
Publicado: (2014)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
por: Moitra, Subhabrata, et al.
Publicado: (2023)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

Anaphylaxis in Brazil between 2011 and 2019
por: Tanno, Luciana Kase, et al.
Publicado: (2022)

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
por: Price, David B, et al.
Publicado: (2016)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11
por: Tanno, Luciana K., et al.
Publicado: (2016)

Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11
por: Tanno, Luciana Kase, et al.
Publicado: (2015)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11
por: Tanno, Luciana Kase, et al.
Publicado: (2016)

Validation of the classification of aria (Allergic rhinitis and its impact on asthma)()
por: Demoly, P., et al.
Publicado: (2003)

Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey
por: Small, Mark, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i3lrt9c27uetj9e2202io445l6